The Macrolide–Lincosamide–Streptogramin B (MLSB) resistance phenotype frequently is recognized among SA and may be constitutive or inducible. Resistance due to MLSB results from alterations in ribosomal antibiotic binding sites mediated by erythromycin ribosomal methylase (erm) genes.